NorthShore University HealthSystem Research Institute is actively looking for companies to co-develop and/or license numerous opportunities in the oncology, diagnostics, and medical device arenas.
Oncology Opportunities
• Novel Cancer Therapy for Epithelial Cancers potentially treats 80% of all cancers
• Chemotherapy Sensitizer drastically improves the selectivity and efficacy of chemotherapy while reducing negative side effects
• New Oncolytic Adenovirus Therapy potentially treats both the primary tumor as well as the metastases
Novel Targets, Methods, and Markers
• New Acute Myocardial Infarction Biomarker could lead to the next generation of diagnostics and therapeutics for AMI.
• Novel Molecular Target that effectively controls cell proliferation and migration could be used for the treatment of cancer, atherosclerosis, wound healing, and inflammation control
• First Known Schizophrenia Susceptibility Gene could be utilized for new treatments and diagnostics.
• New DNA Sequencing Method improves scanning resolution by 1000-fold
• A suite of MRA Enhancements drastically improves current High Resolution, Non-Contrast MR Angiography
Medical Device Opportunities
•Surgical Device: A surgical device that drastically reduces operating time and complexity for procedures requiring tissue separation
• MRI Coil: A new MRI component that drastically improves image quality and contrast.